INISS_B: Q3 sales and EBITDA rose, with EMS strong and Enedo targeting break-even by Q1 next year

About this update from Inission Ab Class B

Q3 saw 13.5% sales growth and improved EBITDA, driven by the Selteka acquisition and EMS strength, while Enedo continued restructuring with significant one-off costs. Break-even for Enedo is targeted for Q1 next year, and full recovery is expected as restructuring costs subside.Based on This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Inission Ab Class B